These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 11051806

  • 1. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y, Shiga S, Tohyama K, Shimatsu A, Ichiyama S.
    Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JW, Andrew M, Delorme M, Ginsberg J, Preissner KT.
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P, Jacquot C, Capron L, Frydman MO, Vignon D, Aiach M.
    Thromb Haemost; 1987 Jun 03; 57(3):263-8. PubMed ID: 3660328
    [Abstract] [Full Text] [Related]

  • 10. Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use.
    Massouh M, Jatoi A, Gordon EM, Ratnoff OD.
    J Lab Clin Med; 1989 Dec 03; 114(6):697-9. PubMed ID: 2592856
    [Abstract] [Full Text] [Related]

  • 11. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis.
    Toulon P, Moulonguet-Doleris L, Costa JM, Aiach M.
    Thromb Haemost; 1991 Jan 23; 65(1):20-4. PubMed ID: 2024235
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Activities of antithrombin III and heparin cofactor II in patients with pathologic blood coagulation conditions].
    Hirokawa S, Kaji T, Tazawa K, Fujimaki M, Hayashi T, Niiya K, Sakuragawa N.
    Rinsho Ketsueki; 1992 Mar 23; 33(3):281-7. PubMed ID: 1578630
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Laboratory determination of heparin cofactor II.
    Ezenagu LC, Brandt JT.
    Arch Pathol Lab Med; 1986 Dec 23; 110(12):1149-51. PubMed ID: 3778142
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y, Aoyagi S, Kusada Y, Miyamoto K.
    J Biomed Mater Res; 1980 Sep 23; 14(5):619-30. PubMed ID: 7349668
    [Abstract] [Full Text] [Related]

  • 20. [A method of determining heparin in blood plasma based on its antithrombin activity].
    Taktashev RE, Suvorova AV, Miller VE, Kolesnikova OI.
    Lab Delo; 1990 Sep 23; (12):59-61. PubMed ID: 1710698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.